NMPA Approval

Salbutamol Sulfate Inhalation Solution

Approval Number

国药准字H20227161

Company上海信谊金朱药业有限公司

Registration Date

December 9, 2022

Previous Approval Numbers

国药准字H19990233

Drug Information

Generic Name

吸入用硫酸沙丁胺醇溶液

Dosage Form

溶液剂（吸入）

Strength

2.5ml：5mg（以沙丁胺醇计）

Drug Type

化学药品

Registration Date

December 9, 2022

Company Information

Applicant Company

Company Name上海信谊金朱药业有限公司

Company Address

上海市金山区亭卫公路6485号

Manufacturing Company

Company Name上海信谊金朱药业有限公司

Company Address

上海市金山区亭卫公路6485号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

吸入用硫酸沙丁胺醇溶液 - NMPA 批准文号 | MedPath